ICD-10-CM · Multi-region

M65.99

Inflammation of synovial tissue or tendon sheaths affecting multiple anatomical sites simultaneously, where the specific type of synovitis or tenosynovitis has not been documented.

Verified May 8, 2026 · 5 sources ↓

Status
Billable
Chapter
13
Related CPT
9
Region
Multi-region
Drawn from CDCICD10DataAAPCUnboundmedicineCMS

Documentation tips

What should appear in the chart to support M65.99.

Source · Editorial brief grounded in 5 cited references ↓

  • Name every joint region and tendon sheath involved — 'multiple sites' in the note is necessary but not sufficient; payers may deny without explicit enumeration of affected locations.
  • State why the synovitis type is unspecified: note the absence of positive cultures, crystal analysis, or imaging findings that would support a more specific code.
  • Document imaging results (ultrasound or MRI) showing synovial thickening or tenosynovial fluid at each affected site — this supports medical necessity and justifies the multi-site designation over a single-site unspecified code.
  • Record any laboratory workup performed or pending (ESR, CRP, RF, anti-CCP) to demonstrate the diagnostic workup attempted before landing on an unspecified code.
  • If this is a transitional or working diagnosis, note the plan to refine it — auditors flag repeated use of unspecified codes without documented diagnostic progression.

Related CPT procedures

Procedure codes commonly billed with M65.99. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

20600 $56.11
Needle aspiration and/or injection of a small joint or bursa — such as a finger or toe joint — performed without ultrasound guidance.
20604 $87.18
Arthrocentesis, aspiration and/or injection of a small joint or bursa (e.g., fingers, toes) performed with ultrasound guidance, including permanent image recording and reporting.
20605 $57.12
Aspiration and/or injection of an intermediate joint or bursa — such as the wrist, elbow, ankle, acromioclavicular joint, or olecranon bursa — performed without ultrasound guidance.
20606 $94.19
Aspiration and/or injection of an intermediate joint or bursa — such as the wrist, elbow, ankle, acromioclavicular, temporomandibular, or olecranon bursa — performed with real-time ultrasound guidance and permanent image recording and reporting.
20610 $68.81
Aspiration and/or injection of a major joint or bursa (shoulder, hip, knee, or subacromial bursa) performed without ultrasound guidance.
20611 $104.21
Aspiration or injection of a major joint or bursa performed under real-time ultrasound guidance, with permanent image documentation.
73564 $49.43
Radiologic examination of the knee consisting of four or more views, including oblique and tunnel projections, for a complete diagnostic workup.
73630 $34.07
Radiologic examination of the foot requiring a minimum of three views, used to evaluate fractures, arthritis, tumors, or structural abnormalities.
76881 $53.78
Complete real-time diagnostic ultrasound of one extremity joint, with recorded images, covering the joint, surrounding muscles, tendons, and other soft tissue structures.

Common coding pitfalls

The recurring mistakes coders make with M65.99 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

  • Assigning M65.99 when only one site is involved — use the site-specific M65.9x code (e.g., M65.91 for shoulder, M65.97 for ankle/foot) instead of the multi-site catch-all.
  • Ignoring the M65 category Excludes1 notes: overuse-related synovitis belongs in M70.–, and chronic crepitant synovitis of the hand/wrist belongs in M70.0–; M65.99 is not a valid substitute.
  • Using M65.99 when a current traumatic injury is the documented cause — S-codes for tendon or ligament injury by body region take precedence per the Excludes1 directive.
  • Defaulting to M65.99 when De Quervain's (M65.4) or trigger finger (M65.3) is clearly documented at one site alongside a vague second-site complaint — code the specific condition for the confirmed site and evaluate whether the second site truly meets criteria.
  • Failing to link M65.99 to a procedure code that makes clinical sense — joint aspiration or injection codes (e.g., 20605, 20610) should reference the specific site treated, and M65.99 alone may not satisfy medical necessity review without site-level detail in the note.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

M65.99 is a FY2026 new code (effective October 1, 2024, no change for FY2026) that captures unspecified synovitis and tenosynovitis when the condition involves multiple sites and the clinical documentation does not support a more specific classification. Use it only when two conditions are both true: (1) more than one joint region or tendon sheath is involved, and (2) the type of synovitis cannot be specified as infective (M65.0–M65.1), abscess (M65.0), calcific (M65.2), trigger finger (M65.3), radial styloid/De Quervain's (M65.4), or other specified (M65.8x). It groups into MS-DRG 557 (Tendonitis, myositis and bursitis with MCC) or 558 (without MCC).

Before assigning M65.99, exhaust more specific options. If the synovitis is tied to overuse, repetitive strain, or pressure, the Excludes1 note at the M65 category level redirects you to M70.– (soft tissue disorders related to use, overuse and pressure). Chronic crepitant synovitis of the hand and wrist is also Excludes1 — use M70.0– instead. If the presentation stems from a current injury, code the injury by body region rather than M65.99.

In orthopedic practice, M65.99 surfaces most often when a patient presents with diffuse inflammatory arthropathy affecting tendons at multiple sites before a definitive diagnosis (e.g., early rheumatoid or seronegative disease) has been established, or when documentation from a consulting provider uses general language across multiple regions. Once a specific etiology or single dominant site is confirmed, transition to the appropriate site-specific or type-specific M65 code.

Sibling codes

Other billable codes under M65.9 (laterality / anatomic variants).

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 5 cited references ↓

01When did M65.99 become a valid code?
M65.99 is a new code effective October 1, 2024 (FY2025) with no change for FY2026. Claims with dates of service before October 1, 2024 cannot use this code.
02What is the difference between M65.99 and M65.90?
M65.90 is unspecified synovitis and tenosynovitis at an unspecified single site. M65.99 is the multi-site version — use it only when documentation clearly identifies involvement at more than one anatomical region.
03Can M65.99 be used for overuse-related synovitis affecting multiple tendons?
No. The M65 category Excludes1 note redirects overuse, repetitive use, and pressure-related soft tissue disorders to M70.–. Assign the appropriate M70 code for occupational or activity-related tenosynovitis.
04Does M65.99 require a modifier for bilateral or multi-site presentation?
M65.99 does not carry a laterality character — it is inherently a multi-site, unspecified code. No additional modifier is needed to convey bilateral or multi-region involvement, but the procedure codes for any interventions performed must still reflect the specific site treated.
05Which MS-DRGs does M65.99 group into?
Under MS-DRG v43.0, M65.99 groups into DRG 557 (Tendonitis, myositis and bursitis with MCC) or DRG 558 (without MCC), consistent with other tendonitis and bursitis diagnoses.
06Should M65.99 be used as a primary diagnosis for an orthopedic office visit?
It can be the primary diagnosis when synovitis or tenosynovitis at multiple sites is the confirmed or working diagnosis driving the encounter. If a more specific type or etiology is established, the more specific M65 code should replace it at that point.
07Is M65.99 appropriate when the provider documents 'inflammatory tenosynovitis' without specifying type?
Yes, if multiple sites are noted and the type is genuinely unspecified. If only one site is mentioned, use the site-specific M65.9x code. If an infective etiology is suspected but not confirmed, the unspecified code is acceptable pending culture results — document the workup.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

  1. 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
  2. 02
    icd10data.com
    https://www.icd10data.com/ICD10CM/Codes/M00-M99/M65-M67/M65-/M65.99
  3. 03
    aapc.com
    https://www.aapc.com/codes/icd-10-codes/M65.99
  4. 04
    unboundmedicine.com
    https://www.unboundmedicine.com/icd/view/ICD-10-CM/1431871/all/M65_99___Unspecified_synovitis_and_tenosynovitis_multiple_sites
  5. 05CMS MS-DRG v43.0 Grouper Documentation

Mira Scribe

Mira AI Scribe captures the names of every affected joint region and tendon sheath, the patient's symptom duration at each site, any imaging findings showing synovial or tenosynovial involvement, and the results or pending status of inflammatory labs — preventing a downcode to a single-site unspecified code and shielding against medical necessity denials that arise when 'multiple sites' appears in a code but nowhere in the clinical note.

See how Mira captures M65.99 documentation

Related ICD-10 codes

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Request Access